The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
Authors:
Open Access
- 1 January 2012
- journal article
- Published by XMLink in Annals of Dermatology
- Vol. 24 (3) , 295-305
Abstract
Kim JH, et al. Ann Dermatol. 2012 Aug;24(3):295-305. http://dx.doi.org/10.5021/ad.2012.24.3.295Keywords
This publication has 20 references indexed in Scilit:
- Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in womenJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2007
- Alfatradiol (0,025 %) - Eine wirksame und sichere Therapieoption zur Behandlung der androgenetischen Alopezie bei Frauen und MännernAktuelle Dermatologie, 2005
- Treatment of female pattern hair loss with oral antiandrogensBritish Journal of Dermatology, 2005
- Androgen action on human skin – from basic research to clinical significanceExperimental Dermatology, 2004
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair lossJournal of the American Academy of Dermatology, 2004
- Decreased Serum Ferritin is Associated With Alopecia in WomenJournal of Investigative Dermatology, 2003
- Testosterone Metabolism in Human Skin Cells in vitro and Its Interaction with Estradiol and DutasterideSkin Pharmacology and Physiology, 2003
- The prevalence and types of androgenetic alopecia in Korean men and womenBritish Journal of Dermatology, 2001
- Patterned androgenic alopecia in womenJournal of the American Academy of Dermatology, 1988
- Lokaltherapie der Alopecia androgenetica mit 17α-ÖstradiolDermatology, 1980